Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells
Project Member(s): Simpson, A.
Funding or Partner Organisation: Pharmacyte Biotech Inc
Start year: 2015
Summary: This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.
Keywords: Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson
FOR Codes: Clinical Sciences, Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes